HB156 deletes a narrowly defined set of provisions from the 2025 First Special Session: Laws 2025 (1st S.S.), Chapter 5, Sections 8 through 13. Those provisions were scheduled to become effective on July 1, 2026; HB156 prevents that emergence by repealing the enumerated sections.
The bill is surgical: it does not amend or replace other provisions of Chapter 5, nor does it add alternative statutory language. Its practical effect depends entirely on what Sections 8–13 would have changed — particularly for agencies, institutions, and programs that were preparing to implement those changes.
For affected actors, the bill creates immediate legal and operational uncertainty about plans tied to the soon-to-be-repealed provisions.
At a Glance
What It Does
The bill repeals Laws 2025 (1st S.S.), Chapter 5, Sections 8–13, thereby preventing those specific special-session provisions from taking effect on their scheduled date. It contains a single operative section: the repeal itself, with no replacement text or grandfathering language.
Who It Affects
State agencies that began rulemaking or implementation planning under the 2025 special-session provisions, educational institutions and health providers that would have complied with new vaccination rules, and individuals whose obligations or rights would have changed under Sections 8–13 are directly affected. Local public-health authorities and insurers may also see downstream effects.
Why It Matters
Because the repeal blocks a set of imminent statutory changes, agencies must reassess implementation steps already taken, regulated parties must pause compliance changes tied to the repealed sections, and legal counsel must review whether any administrative actions taken under the soon-to-be-repealed authority remain valid.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
HB156 is a one‑section bill that excises a targeted subset of the 2025 special-session vaccination statute: Sections 8 through 13 of Chapter 5. It does not substitute new policy, alter other chapters, or enumerate transitional rules; its only stated command is to repeal the listed sections.
That means the substantive content and legal effects of Sections 8–13 vanish from the statute books if this bill becomes law.
Because the repealed text was scheduled to take effect July 1, 2026, the practical work before agencies and regulated entities is backwards-looking: stop executing any implementation tied exclusively to those sections and assess whether existing policies relied on other statutory authority. If any regulations or administrative rules were adopted that depended on the repealed sections, agencies will need to determine whether those rules remain authorized, must be rescinded, or require emergency action to preserve continuity of services.The bill leaves open whether any conduct already governed by pre‑existing law will change.
In other words, HB156 removes the prospective changes but does not explicitly address the status of actions already taken under the soon-to-be-repealed sections, nor does it provide funding, guidance, or a transition plan. That gap shifts the next step to state agencies and regulated parties to sort operational consequences and potential litigation risk.
The Five Things You Need to Know
The bill repeals Laws 2025 (1st S.S.), Chapter 5, Sections 8 through 13 — a narrowly targeted excision of part of the 2025 special-session vaccination statute.
Those specific sections were scheduled to become effective on July 1, 2026; HB156 prevents their scheduled activation by removing them from the session law.
HB156 contains only a repeal; it does not add replacement provisions, transitional rules, or explicit guidance for actions already taken under the soon-to-be-repealed authority.
Because the repeal is limited to Sections 8–13, other parts of Laws 2025 (1st S.S.), Chapter 5 remain intact and continue to govern where they do not rely on the deleted sections.
State agencies that began rulemaking, schools and health-care providers that prepared compliance programs, and anyone whose duties or rights would have depended on Sections 8–13 must reassess implementation plans and possible regulatory gaps.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Direct repeal of enumerated session-law sections
This single operative clause removes Laws 2025 (1st S.S.), Chapter 5, Sections 8–13 from the statutory record. Mechanically, the repeal treats those sections as if they were never enacted; any authority or requirements created exclusively by those sections would cease to exist once the repeal is effective. Practically, this is narrower than an amendment — it excises whole pieces of the session law rather than altering language within the current code.
Repeal is limited and non‑substitutive
HB156 does not touch other sections of Chapter 5 or other session-law chapters; it does not create new statutory text to replace or modify the repealed provisions. That means downstream responsibilities, enforcement mechanisms, penalties, or reporting requirements that would have come from Sections 8–13 are simply removed, not redirected. Regulated parties cannot point to HB156 for transitional rules because none are provided.
Operational implications for agencies and regulated entities
Because the targeted sections were slated to take effect on a fixed future date, the repeal primarily affects implementation timelines: agencies must halt actions that relied on the soon-to-be-deleted authority, revisit any draft or final rules premised on it, and decide whether to reissue rules grounded in other statutory authority. The lack of transitional language creates questions about existing administrative acts taken in anticipation of the effective date — for example, whether permits, orders, or guidance issued under the repealed sections remain valid or must be reissued.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Individuals and families opposing the specific 2025 special-session vaccination measures — repeal forestalls any new obligations, mandates, or penalties that would have been imposed by Sections 8–13.
- Entities that would have faced new regulatory burdens under Sections 8–13, such as certain employers, schools, or health facilities; repeal removes those impending statutory duties and any immediate compliance costs.
- Stakeholders seeking policy continuity who prefer existing law over the special-session changes — repeal preserves the pre‑2025 statutory baseline rather than introducing the scheduled modifications.
Who Bears the Cost
- State agencies (e.g., Department of Health, boards overseeing professional licensure) that expended staff time and resources preparing rules, guidance, or enforcement frameworks based on Sections 8–13 — those sunk implementation costs yield no lasting statutory authority.
- Organizations that began structural or operational changes expecting the new rules (schools, large employers, health systems) face uncertainty: plans may need reversal, procurement contracts renegotiated, and training programs halted — all producing administrative expense.
- Individuals or groups who supported the now‑repealed provisions (for example, advocates for expanded public-health powers) lose the policy change they anticipated; public-health offices may confront gaps in their toolkit if Sections 8–13 would have provided additional authority.
Key Issues
The Core Tension
The bill resolves one problem — stopping a set of imminent statutory changes — but deepens another: eliminating those provisions without offering replacements forces a choice between legal consistency and policy certainty. Repeal preserves the prior legal baseline and prevents potentially controversial new mandates, yet it simultaneously creates operational uncertainty for agencies and regulated parties that had already moved to implement the scheduled changes. That trade‑off — stability of the old regime versus clarity and enforceability of a new one — is the central dilemma HB156 leaves unresolved.
The most immediate implementation challenge is procedural: agencies that already adopted rules or issued guidance tied to Sections 8–13 must decide whether those administrative acts remain authorized. Because HB156 contains no transitional language, courts could be asked to resolve whether specific administrative actions taken under the soon-to-be-repealed provisions are valid, whether obligations imposed before repeal survive, or whether affected parties are entitled to relief.
A second tension is practical versus legal authority. Removing statutory text does not erase operational realities: vaccination programs, reporting systems, contracts, and training developed in expectation of the sections' effect may continue to exist in practice even without statutory backing, creating compliance confusion.
Finally, the bill's narrow scope leaves open strategic choices for policymakers: repeal buys time but does not resolve the underlying policy debate that produced the 2025 changes, meaning agencies and stakeholders will need a separate, deliberate process to address any substantive public‑health gaps or policy objectives originally targeted by Sections 8–13.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.